Charles River Laboratories CRL Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligations.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's long-term debt?
- Charles River Laboratories (CRL) reported long-term debt of $2.66B in Q1 2026.
- How has Charles River Laboratories's long-term debt changed year-over-year?
- Charles River Laboratories's long-term debt increased by 6.1% year-over-year, from $2.51B to $2.66B.
- What is the long-term trend for Charles River Laboratories's long-term debt?
- Over 5 years (2020 to 2025), Charles River Laboratories's long-term debt has grown at a 2.1% compound annual growth rate (CAGR), from $1.93B to $2.14B.
- What does long-term debt mean?
- Debt that is not due for repayment within the next year.
- How do you interpret long-term debt?
- An increase indicates higher leverage and potential interest burden, while a decrease signals debt repayment and improved solvency.
- How does long-term debt compare across companies?
- Varies by capital structure strategy; compared against peers using debt-to-equity or net debt-to-EBITDA ratios.